Naturally occurring seco- and nor-polycyclic polyprenylated acylphloroglucinols: distribution, structural diversity, andbiological activity.
10.1016/S1875-5364(25)60911-3
- Author:
Yulin DUAN
1
;
Ying TANG
2
;
Changxing QI
3
;
Yonghui ZHANG
4
Author Information
1. Department of Pharmacy, Traditional Chinese and Western Medicine Hospital of Wuhan, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China; Department of Pharmacy, Wuhan No. 1 Hospital, Wuhan 430022, China.
2. Department of Pharmacy, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430033, China. Electronic address: 10280921@qq.com.
3. Hubei Key Laboratory of Natural Medicinal Chemistry and Resource Evaluation, School of Pharmacy, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China. Electronic address: qichangxing@hust.edu.cn.
4. Hubei Key Laboratory of Natural Medicinal Chemistry and Resource Evaluation, School of Pharmacy, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China. Electronic address: zhangyh@mails.tjmu.edu.cn.
- Publication Type:Review
- Keywords:
Biological activity;
Chemical structure;
Natural products;
Nor-polycyclic polyprenylated acylphloroglucinols;
Seco-polycyclic polyprenylated acylphloroglucinols
- MeSH:
Phloroglucinol/analogs & derivatives*;
Humans;
Molecular Structure;
Animals;
Clusiaceae/chemistry*;
Plant Extracts/pharmacology*;
Biological Products/pharmacology*
- From:
Chinese Journal of Natural Medicines (English Ed.)
2025;23(7):824-837
- CountryChina
- Language:English
-
Abstract:
Polycyclic polyprenylated acylphloroglucinols (PPAPs) represent a distinct subclass of specialized metabolites predominantly found in the plant kingdom, particularly within the Guttiferae (Clusiaceae) family. These compounds exhibit remarkable structural diversity and a wide range of biological activities. Seco- and nor-PPAPs, two unique variants of PPAPs with diverse skeletal structures, have been extensively investigated. As of June 2023, 200 compounds have been isolated from four genera, with Hypericum being the primary source. Notably, 115 of these compounds were identified in the past four years, indicating a significant increase in research activity. Seco- and nor-PPAPs can be categorized into six main subgroups based on the original PPAP scaffolds. Biological studies have revealed their potential in various therapeutic applications, including anti-cancer, anti-inflammatory, hepatoprotective, anti-Alzheimer's disease (anti-AD), multidrug resistance (MDR) reversal, anti-depressant, neuroprotective, and immunosuppressive effects. This review provides a comprehensive overview of the occurrence, structures, and bioactivities of natural seco- and nor-PPAPs, offering valuable insights for the further development of PPAPs.
